The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Label-Free Drug Discovery Market Research Report 2024
Synopsis
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Drug Discovery Service are specifically designed to minimize the costs and timelines of drug discovery.Skipping the tedious labeling and optimization steps required by other drug screening technologies, the label-free method eliminates the long time, higher cost and false positive results required by traditional detection methods.
The global Label-Free Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Label-Free Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Label-Free Drug Discovery.
Report Scope
The Label-Free Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Label-Free Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Label-Free Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
GE Healthcare
Corning
Albany Molecular Research, Inc (AMRI)
Charles River Laboratories
Evotec
Jubilant Biosys
WuXi AppTec
Agilent
SAMDI Tech
Segment by Type
Cellular Dielectric Spectroscopy
Bio-layer Interferometry
Surface Plasmon Resonance
Optical Waveguide Grating Technology
Segment by Application
Pharmaceutical Companies
Research Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Label-Free Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Drug Discovery Service are specifically designed to minimize the costs and timelines of drug discovery.Skipping the tedious labeling and optimization steps required by other drug screening technologies, the label-free method eliminates the long time, higher cost and false positive results required by traditional detection methods.
The global Label-Free Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Label-Free Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Label-Free Drug Discovery.
Report Scope
The Label-Free Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Label-Free Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Label-Free Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
GE Healthcare
Corning
Albany Molecular Research, Inc (AMRI)
Charles River Laboratories
Evotec
Jubilant Biosys
WuXi AppTec
Agilent
SAMDI Tech
Segment by Type
Cellular Dielectric Spectroscopy
Bio-layer Interferometry
Surface Plasmon Resonance
Optical Waveguide Grating Technology
Segment by Application
Pharmaceutical Companies
Research Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Label-Free Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Label-Free Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cellular Dielectric Spectroscopy
1.2.3 Bio-layer Interferometry
1.2.4 Surface Plasmon Resonance
1.2.5 Optical Waveguide Grating Technology
1.3 Market by Application
1.3.1 Global Label-Free Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Research Laboratories
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Label-Free Drug Discovery Market Perspective (2019-2030)
2.2 Label-Free Drug Discovery Growth Trends by Region
2.2.1 Global Label-Free Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Label-Free Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Label-Free Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Label-Free Drug Discovery Market Dynamics
2.3.1 Label-Free Drug Discovery Industry Trends
2.3.2 Label-Free Drug Discovery Market Drivers
2.3.3 Label-Free Drug Discovery Market Challenges
2.3.4 Label-Free Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Label-Free Drug Discovery Players by Revenue
3.1.1 Global Top Label-Free Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Label-Free Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Label-Free Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Label-Free Drug Discovery Revenue
3.4 Global Label-Free Drug Discovery Market Concentration Ratio
3.4.1 Global Label-Free Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Label-Free Drug Discovery Revenue in 2023
3.5 Label-Free Drug Discovery Key Players Head office and Area Served
3.6 Key Players Label-Free Drug Discovery Product Solution and Service
3.7 Date of Enter into Label-Free Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Label-Free Drug Discovery Breakdown Data by Type
4.1 Global Label-Free Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Label-Free Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Label-Free Drug Discovery Breakdown Data by Application
5.1 Global Label-Free Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Label-Free Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Label-Free Drug Discovery Market Size (2019-2030)
6.2 North America Label-Free Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Label-Free Drug Discovery Market Size by Country (2019-2024)
6.4 North America Label-Free Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Label-Free Drug Discovery Market Size (2019-2030)
7.2 Europe Label-Free Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Label-Free Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Label-Free Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Label-Free Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Label-Free Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Label-Free Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Label-Free Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Label-Free Drug Discovery Market Size (2019-2030)
9.2 Latin America Label-Free Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Label-Free Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Label-Free Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Label-Free Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Label-Free Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Label-Free Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Label-Free Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Label-Free Drug Discovery Introduction
11.1.4 Thermo Fisher Scientific Revenue in Label-Free Drug Discovery Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Label-Free Drug Discovery Introduction
11.2.4 GE Healthcare Revenue in Label-Free Drug Discovery Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 Corning
11.3.1 Corning Company Detail
11.3.2 Corning Business Overview
11.3.3 Corning Label-Free Drug Discovery Introduction
11.3.4 Corning Revenue in Label-Free Drug Discovery Business (2019-2024)
11.3.5 Corning Recent Development
11.4 Albany Molecular Research, Inc (AMRI)
11.4.1 Albany Molecular Research, Inc (AMRI) Company Detail
11.4.2 Albany Molecular Research, Inc (AMRI) Business Overview
11.4.3 Albany Molecular Research, Inc (AMRI) Label-Free Drug Discovery Introduction
11.4.4 Albany Molecular Research, Inc (AMRI) Revenue in Label-Free Drug Discovery Business (2019-2024)
11.4.5 Albany Molecular Research, Inc (AMRI) Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Detail
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Label-Free Drug Discovery Introduction
11.5.4 Charles River Laboratories Revenue in Label-Free Drug Discovery Business (2019-2024)
11.5.5 Charles River Laboratories Recent Development
11.6 Evotec
11.6.1 Evotec Company Detail
11.6.2 Evotec Business Overview
11.6.3 Evotec Label-Free Drug Discovery Introduction
11.6.4 Evotec Revenue in Label-Free Drug Discovery Business (2019-2024)
11.6.5 Evotec Recent Development
11.7 Jubilant Biosys
11.7.1 Jubilant Biosys Company Detail
11.7.2 Jubilant Biosys Business Overview
11.7.3 Jubilant Biosys Label-Free Drug Discovery Introduction
11.7.4 Jubilant Biosys Revenue in Label-Free Drug Discovery Business (2019-2024)
11.7.5 Jubilant Biosys Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec Label-Free Drug Discovery Introduction
11.8.4 WuXi AppTec Revenue in Label-Free Drug Discovery Business (2019-2024)
11.8.5 WuXi AppTec Recent Development
11.9 Agilent
11.9.1 Agilent Company Detail
11.9.2 Agilent Business Overview
11.9.3 Agilent Label-Free Drug Discovery Introduction
11.9.4 Agilent Revenue in Label-Free Drug Discovery Business (2019-2024)
11.9.5 Agilent Recent Development
11.10 SAMDI Tech
11.10.1 SAMDI Tech Company Detail
11.10.2 SAMDI Tech Business Overview
11.10.3 SAMDI Tech Label-Free Drug Discovery Introduction
11.10.4 SAMDI Tech Revenue in Label-Free Drug Discovery Business (2019-2024)
11.10.5 SAMDI Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
